Protocol Ledger

NCT04727073 · Phase III · TERMINATED

Spironolactone in the Treatment of Heart Failure

Interventional Phase III clinical trial protocol NCT04727073 sponsored by Charite University, Berlin, Germany in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-11-01 Enrollment: 743 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04727073
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)743 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04727073
Protocol FieldVerified Registry Value
NCT IdentifierNCT04727073
Consolidated Lead SponsorCharite University, Berlin, Germany
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusTERMINATED
Registered Enrollment743 participants (ACTUAL)
Registered Start Date2018-11-01
WhyStopped ClassificationInsufficient / Slow Accrual

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04727073
Hospital Research SiteLocationSite Profile
Medical University of ViennaVienna, AustriaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI